|
INTS4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.851510E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.348200E-02 |
| Normal-vs-Stage2 |
3.329600E-02 |
| Normal-vs-Stage3 |
8.718600E-03 |
| Normal-vs-Stage4 |
3.802100E-03 |
| Stage1-vs-Stage2 |
2.804800E-01 |
| Stage1-vs-Stage3 |
1.042640E-01 |
| Stage1-vs-Stage4 |
9.190000E-02 |
| Stage2-vs-Stage3 |
9.161000E-01 |
| Stage2-vs-Stage4 |
6.783200E-01 |
| Stage3-vs-Stage4 |
7.154800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.542200E-02 |
| Normal-vs-AfricanAmerican |
8.455400E-01 |
| Normal-vs-Asian |
2.746000E-01 |
| Caucasian-vs-AfricanAmerican |
1.777380E-01 |
| Caucasian-vs-Asian |
2.754200E-01 |
| AfricanAmerican-vs-Asian |
5.212200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.403500E-03 |
| Normal-vs-Female |
5.140400E-02 |
| Male-vs-Female |
6.051600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.167400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.027700E-02 |
| Normal-vs-Age(61-80Yrs) |
8.664800E-03 |
| Normal-vs-Age(81-100Yrs) |
6.511800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.418200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.117900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.589600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.369800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.813800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.043400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.911900E-02 |
| Classical-VS-Follicular |
1.425740E-04 |
| Classical-VS-Other |
3.627800E-01 |
| Classical-VS-Normal |
2.370600E-01 |
| Tall-VS-Follicular |
5.794000E-01 |
| Tall-VS-Other |
8.356200E-01 |
| Tall-VS-Normal |
8.302900E-03 |
| Follicular-VS-Other |
6.396400E-01 |
| Follicular-VS-Normal |
3.576800E-04 |
| Other-VS-Normal |
1.922590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.917100E-03 |
| Normal-vs-N1 |
3.076100E-03 |
| N0-vs-N1 |
5.008800E-01 |
|
|
